(19)
(11) EP 1 377 312 A1

(12)

(43) Date of publication:
07.01.2004 Bulletin 2004/02

(21) Application number: 02725277.4

(22) Date of filing: 22.03.2002
(51) International Patent Classification (IPC)7A61K 38/48, A01N 43/32, A01N 43/50, A01N 37/18, A01N 31/08
(86) International application number:
PCT/US2002/008656
(87) International publication number:
WO 2002/076496 (03.10.2002 Gazette 2002/40)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 22.03.2001 US 277625 P

(71) Applicant: Van Andel Institute
Grand Rapids, MI 49503 (US)

(72) Inventors:
  • DUESBERY, Nicholas, S.
    Grand Rapids, MI 49503 (US)
  • WEBB, Craig, P.
    Grand Rapids, MI 49341 (US)
  • VANDE WOUDE, George, F.
    Ada, MI 49301 (US)

(74) Representative: Wright, Simon Mark 
J.A. Kemp & Co.14 South SquareGray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) ANTHRAX LETHAL FACTOR INHIBITS TUMOR GROWTH AND ANGIOGENESIS